Jane Lapon: News & Coverage - MoneyMakers

Topics

Startup stories Company stories Markets & events People & wealth Family offices

AI & automation

Business automation Industry AI Agents & tools Physical AI

Funding & fundraising Startups & growth Business & growth Acquisitions & ownership

People

All people Investors Angel investors Wealth Founders Boards Executives Leadership changes Get your profile

New Wealth

Explore New Wealth After a business sale Navigating an inheritance Employee equity payouts Large investment gains

Connections Startups Companies Investors Directory Library Get Featured

WatchlistSign in

Home
People
Jane Lapon
Coverage

JL

MoneyMakers coverage

Jane Lapon: news & coverage

Page 1 of 1 · 1 report

Founder of kidney-therapy developer Atorvia.

Published reporting on Jane Lapon. Entries describe developments as reported on their publication dates.

All reporting

Conceptual illustration of a microscope examining a kidney-shaped image on a tissue slide, with the name Atorvia against a dark green background.

Startups & growth Analysis

Atorvia develops a potential drug to prevent kidney failure after heart surgery

Atorvia is developing potential kidney medicines, including an approach intended for use before cardiac surgery, with laboratory and mentoring support.

About Branding Family Offices Articles Stock movers Opportunities List a Business Business Ideas Validate Founders to Watch Get Featured Pricing Business Terms T&C Privacy Refunds Contact

All publications RSS News RSS Guides RSS